Brief: India's Marksans Pharma Sept-qtr consol profit rises
13/11/2017 07:20
Nov 13 (Reuters) - Marksans Pharma Ltd MARK.NS :
* Sept quarter consol profit 104.1 million rupees versus
profit of
7.5 million rupees year ago
* Sept quarter consol revenue from operations 2.74 billion
rupees
versus 1.80 billion rupees year ago
Source text - http://bit.ly/2jl6Fbt
Further company coverage: MARK.NS
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Marksans Pharma
See all newsIndia's Marksans Pharma jumps to over 18-month high after more than doubling quarterly profit
Brief: Marksans Pharma Ltd To Acquire 100% Of Netherlands-Based Qliniq B.V
India's Marksans Pharma jumps to 10-month high after Q4 profit rise
Brief: Marksans Pharma March-Quarter Consol Net Profit 1.48 Billion Rupees
Brief: Marksans Pharma Ltd Receives USFDA Approval For Benzonatate Capsules USP, 100 Mg & 200 Mg